The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
5.85
+0.20 (3.54%)
At close: Jul 9, 2026, 4:00 PM EDT
5.84
-0.01 (-0.17%)
After-hours: Jul 9, 2026, 7:58 PM EDT
The Oncology Institute Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 30.28 | 33.57 | 49.67 | 33.49 | 14.01 | 115.17 |
Short-Term Investments | - | - | - | 49.37 | 59.8 | - |
Cash & Short-Term Investments | 30.28 | 33.57 | 49.67 | 82.86 | 73.81 | 115.17 |
Cash Growth | -23.80% | -32.42% | -40.05% | 12.26% | -35.92% | 1820.21% |
Accounts Receivable | 58.13 | 59 | 48.34 | 42.36 | 39.82 | 20.01 |
Other Receivables | 1.32 | 0.32 | 0.35 | 0.55 | 0.62 | 1.24 |
Total Trade Receivables | 59.45 | 59.32 | 48.68 | 42.91 | 40.43 | 21.24 |
Inventory | 24.29 | 16.88 | 10.04 | 13.68 | 9.26 | 6.44 |
Other Current Assets | 2.84 | 2.99 | 4.03 | 4.05 | 6.92 | 11.2 |
Total Current Assets | 116.86 | 112.75 | 112.42 | 143.49 | 130.42 | 154.06 |
Net Property, Plant & Equipment | 33.22 | 33.06 | 37.67 | 40.05 | 33.04 | 4.19 |
Other Intangible Assets | 10.3 | 11.02 | 14.81 | 17.9 | 17.96 | 18.25 |
Goodwill | 7.23 | 7.23 | 7.23 | 7.23 | 21.42 | 26.63 |
Long-Term Investments | - | - | - | - | 58.35 | - |
Other Long-Term Assets | 0.62 | 0.61 | 0.59 | 0.56 | 0.48 | 0.32 |
Total Assets | 168.23 | 164.66 | 172.72 | 209.24 | 261.67 | 203.44 |
Accounts Payable | 47.65 | 43.17 | 24.32 | 14.43 | 9.37 | 15.56 |
Accrued Expenses | 24.3 | 20.64 | 21.09 | 14 | 14.85 | 14.06 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.18 |
Current Portion of Leases | 7.4 | 7.16 | 6.8 | 6.36 | 5.5 | - |
Total Current Liabilities | 79.35 | 70.96 | 52.22 | 34.79 | 29.72 | 29.8 |
Long-Term Debt | 78.61 | 77.4 | 93.13 | 86.83 | 80.62 | - |
Long-Term Leases | 18.84 | 19.13 | 23.22 | 26.49 | 22.06 | - |
Other Long-Term Liabilities | 7.71 | 12.88 | 0.56 | 4.12 | 6.09 | 69.48 |
Total Long-Term Liabilities | 105.16 | 109.41 | 116.91 | 117.43 | 108.77 | 69.48 |
Total Liabilities | 184.52 | 180.38 | 169.13 | 152.22 | 138.49 | 99.28 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
Treasury Stock | -1.02 | -1.02 | -1.02 | -1.02 | - | - |
Additional Paid-in Capital | 258.64 | 256.71 | 215.41 | 204.19 | 186.25 | 167.39 |
Retained Earnings | -273.91 | -271.42 | -210.81 | -146.15 | -63.08 | -63.23 |
Total Common Shareholders' Equity | -16.29 | -15.72 | 3.59 | 57.03 | 123.18 | 104.16 |
Shareholders' Equity | -16.29 | -15.72 | 3.59 | 57.03 | 123.17 | 104.16 |
Total Liabilities & Equity | 168.23 | 164.66 | 172.72 | 209.24 | 261.67 | 203.44 |
Total Debt | 104.86 | 103.69 | 123.15 | 119.68 | 108.18 | 0.18 |
Net Cash (Debt) | -74.58 | -70.12 | -73.48 | -36.82 | -34.37 | 114.99 |
Net Cash Per Share | -0.76 | -0.76 | -0.98 | -0.50 | -0.43 | 1.74 |
Book Value | -16.29 | -15.72 | 3.59 | 57.03 | 123.18 | 104.16 |
Book Value Per Share | -0.17 | -0.17 | 0.05 | 0.77 | 1.53 | 1.57 |
Tangible Book Value | -33.82 | -33.97 | -18.45 | 31.89 | 83.8 | 59.29 |
Tangible Book Value Per Share | -0.34 | -0.37 | -0.25 | 0.43 | 1.04 | 0.90 |